Eurofins Viracor: All Resources

Watch the on-demand webinar where we’ll examine the diagnostic challenges of endemic mycoses, including histoplasmosis and coccidioidomycosis. Learn how emerging tools are helping overcome limitations in identifying dimorphic fungi and improving outcomes in invasive fungal infections. The session features expert insights and a live Q&A. Don’t miss this opportunity to advance your understanding of fungal diagnostics.

Now available on-demand: A case-based webinar on non-tuberculous mycobacterial (NTM) PCR testing, exploring its clinical implications and practical applications. Discover how rapid PCR testing has advanced the detection and management of NTM infections. Dr. Mirza Haider Ali shares real-world insights into how timely, accurate diagnostics can support earlier intervention and improve patient outcomes.

Eurofins Viracor’s white paper details the analytical validation of a hybrid capture sequencing assay for detecting invasive fungal and bacterial infections (IFBIs) from plasma and BAL samples. The assay demonstrated high sensitivity and specificity, with strong concordance to qPCR results and reduced polymicrobial reporting. This targeted approach enhances diagnostic accuracy and interpretability, especially for immunocompromised patients.

Join us for a case-based webinar on the critical role of rapid fungal infection detection in transplant recipients. Dr. Daniel Z. Friedman, MD, will showcase real-world examples demonstrating how rapid PCR testing enhances clinical decision-making and improves patient outcomes. Learn how timely diagnostic insights can support effective treatment when every moment counts. Explore cutting-edge testing solutions that can make a life-saving difference.

View this engaging webinar hosted by Eurofins Viracor, exploring the potential of Torque Teno Virus (TTV) as a biomarker for immune function. TTV plasma load has been shown to reflect the host’s immune status, making it a valuable tool for immunologic monitoring. Research indicates that TTV load is linked to both rejection and infection in solid organ transplant recipients, offering critical insights for patient management...

Download our TTV Risk Stratification Guide to learn more about how TTV monitoring can enhance transplant patient management and improve clinical outcomes.

This interesting presentation will review The University of Nebraska's Kidney Transplant program's strategy of using CMV inSIGHT T Cell Immunity testing to serially monitor high risk kidney transplant patients to evaluate if prophylaxis could be discontinued early. Dr. Clifford Miles will review data originally presented at the Cutting Edge of Transplantation earlier this year. Dr. Miles is the Medical Director of Kidney and Pancreas Transplant at the University of Nebraska's Medical Center and Associate Professor, Nephrology Division at UNMC's college of medicine. 

Join us for an insightful presentation with real-world data and patient case studies utilizing the CMV inSIGHT™ T Cell Immunity test. Identify how you can utilize this cell mediated immunity assay in your immunocompromised patients to evaluate their immune response to CMV. These answers can assist in personalizing your approach to your patients CMV antiviral therapy.

In this episode of the Eurofins Viracor podcast listen to our Transplant Radio interview series part 2 from ATC 2022 in Boston. We exhibited as Eurofins Transplant, which is comprised of Eurofins Viracor, Eurofins Transplant Genomics, Eurofins Donor & Product Testing (DPT), Eurofins Ascend Clinical and Eurofins CellTx.

In this episode of the Eurofins Viracor podcast listen to our Transplant Radio interview series part 3 from ATC 2022 in Boston. We exhibited as Eurofins Transplant, which is comprised of Eurofins Viracor, Eurofins Transplant Genomics, Eurofins Donor & Product Testing (DPT), Eurofins Ascend Clinical and Eurofins CellTx.